| Absorption |
| Blood-Brain Barrier | BBB- | 0.9954 |
| Human Intestinal Absorption | HIA- | 0.9112 |
| Caco-2 Permeability | Caco2- | 0.7812 |
| P-glycoprotein Substrate | Substrate | 0.5274 |
| P-glycoprotein Inhibitor | Non-inhibitor | 0.9447 |
| Non-inhibitor | 0.9872 |
| Renal Organic Cation Transporter | Non-inhibitor | 0.9620 |
| Distribution |
| Subcellular localization | Lysosome | 0.4474 |
| Metabolism |
| CYP450 2C9 Substrate | Non-substrate | 0.7684 |
| CYP450 2D6 Substrate | Non-substrate | 0.8611 |
| CYP450 3A4 Substrate | Non-substrate | 0.5946 |
| CYP450 1A2 Inhibitor | Non-inhibitor | 0.8778 |
| CYP450 2C9 Inhibitor | Non-inhibitor | 0.9259 |
| CYP450 2D6 Inhibitor | Non-inhibitor | 0.9350 |
| CYP450 2C19 Inhibitor | Non-inhibitor | 0.9206 |
| CYP450 3A4 Inhibitor | Non-inhibitor | 0.8921 |
| CYP Inhibitory Promiscuity | Low CYP Inhibitory Promiscuity | 0.9761 |
| Excretion |
| Toxicity |
| Human Ether-a-go-go-Related Gene Inhibition | Weak inhibitor | 0.9997 |
| Non-inhibitor | 0.9091 |
| AMES Toxicity | Non AMES toxic | 0.8884 |
| Carcinogens | Non-carcinogens | 0.6178 |
| Fish Toxicity | High FHMT | 0.9443 |
| Tetrahymena Pyriformis Toxicity | High TPT | 0.8432 |
| Honey Bee Toxicity | Low HBT | 0.7087 |
| Biodegradation | Not ready biodegradable | 0.9760 |
| Acute Oral Toxicity | IV | 0.6502 |
| Carcinogenicity (Three-class) | Non-required | 0.6952 |